AstraZeneca has announced a £300 million investment into the UK’s life sciences sector, providing a boost to jobs and research development. However, global businesses are facing pressure as supply chains are disrupted by geopolitical tensions.\n\nMajor brands have warned of logistical difficulties, highlighting broader issues affecting global retail and distribution. UK banks have reported mixed financial results, reflecting uncertainty in the wider economy.
Global Businesses Pivot to Resilience and Automation Amid Market Uncertainty
Businesses worldwide continue adapting to uncertain market conditions and rising operating costs. Technology companies remain among the strongest-performing sectors as demand for artificial intelligence and cloud services continues growing rapidly.…
